Summary
- The Federal Trade Commission has filed a contempt motion against Amare Global Holdings and three individuals for allegedly violating an FTC order prohibiting false health claims.
- The motion targets former Chief Science Officer Shawn Talbott, brand partner Patrick Hintze, and current CEO David Chung for misleading consumers about dietary supplements' efficacy for conditions like depression and ADHD.
- The FTC claims these parties acted in concert to promote unsubstantiated health benefits, despite knowing of Talbott's prior order from 2005 that bans such representations.
- This action emphasizes the FTC's commitment to consumer protection and could lead to compensatory damages for affected consumers.
Join the discussion — sign up to comment, upvote, and save articles.